Terbogrel

Generic Name: Terbogrel

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₂₇N_₅O_₂

CAS Number: 149979-74-8

Unique Ingredient Identifier: 5Z4KWQ5OGN

Background: Terbogrel has been used in trials studying the treatment of Hypertension, Pulmonary.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Terbogrel
Drug: Clopidogrel

First Posted Date: 2014-08-22

Last Posted Date: 2014-08-22

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 14

Registration Number: NCT02222987

Safety of Terbogrel in Patients With Primary Pulmonary Hypertension

Phase 2

Terminated

Conditions: Hypertension, Pulmonary

Interventions: Drug: Terbogrel

First Posted Date: 2014-08-22

Last Posted Date: 2014-08-22

Lead Sponsor: Boehringer Ingelheim

Target Recruit Count: 33

Registration Number: NCT02223494

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy